As of March 2023 Evolent Health has a market cap of $3.40 Billion. This makes Evolent Health the world's 2913th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $3.40 B | 19.67% |
2022 | $2.84 B | 14.85% |
2021 | $2.47 B | 82.95% |
2020 | $1.35 B | 76.64% |
2019 | $0.76 B | -51.53% |
2018 | $1.57 B | 71.94% |
2017 | $0.91 B | 18.05% |
2016 | $0.77 B | 54.86% |
2015 | $0.50 B |
On Mar 23rd, 2023 the market cap of Evolent Health was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() National Healthcare
NHC | $0.88 B | -73.98% | ๐บ๐ธ USA |
![]() Global Cord Blood CO | $0.40 B | -88.23% | ๐ญ๐ฐ Hong Kong |
![]() Graham Holdings GHC | $2.75 B | -19.12% | ๐บ๐ธ USA |
![]() CryoLife CRY | $0.70 B | -79.32% | ๐บ๐ธ USA |